Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis

Table 2

Depressive symptoms correlated with medication in rheumatoid arthritis.

Medication	Pseudo	AICc	Coefficient	Odds ratio (95% CI)	value
Biological medications	0.154	572.98
None			0.059	1.06 (0.83–1.37)	0.643
Abatacept			−0.143	0.87 (0.45–1.52)	0.642
Adalimumab			−0.143	0.87 (0.45–1.52)	0.642
Etanercept			0.011	1.01 (0.72–1.41)	0.948
Golimumab			0.011	1.01 (0.43–2.03)	0.978
Infliximab			0.113	1.12 (0.73–1.66)	0.588
Rituximab			0.145	1.16 (0.85–1.57)	0.361
Tocilizumab			−0.351	0.70 (0.52–0.95)	0.023
Classic medications	0.829	478.81
Leflunomide			−0.284	0.75 (0.56–1.01)	0.061
Methotrexate			−0.207	0.81 (0.62–1.06)	0.125
Leflunomide and Methotrexate			0.301	1.35 (0.82–2.12)	0.209
Sulfasalazine			−0.546	0.58 (0.37–0.87)	0.012
Hydroxychloroquine + Leflunomide + Methotrexate			−0.441	0.64 (0.31–1.17)	0.184
Hydroxychloroquine + Methotrexate			0.090	1.09 (0.73–1.60)	0.650
Cyclosporine			0.029	1.03 (0.46–1.98)	0.937
Hydroxychloroquine + Leflunomide			−0.258	0.77 (0.30–1.61)	0.539
Sulfasalazine + Methotrexate			0.147	1.16 (0.70–1.86)	0.565
Hydroxychloroquine			0.147	1.16 (0.68–1.86)	0.565
Sulfasalazine + Hydroxychloroquine			0.147	1.16 (0.68–1.86)	0.565
Sulfasalazine + Leflunomide			−1.357	0.26 (0.04–0.81)	0.057